Herpes Zoster Vaccination (SHINGLES)

Service Description

SHINGRIX® Zoster Vaccine (Recombinant) WHAT IS SHINGLES? Shingles is a painful rash that usually develops on one side of the body, often the face or torso. The rash consists of blisters that typically scab over in 7 to 10 days and clears up within 2 to 4 weeks. Some people describe the pain as an intense burning sensation. This long-lasting pain is called postherpetic neuralgia (PHN), and it is the most common complication of shingles. Your risk of getting shingles and PHN increases as you get older. 99% of people over 50 years of age are living with the virus that causes shingles and 1 in 3 people will experience shingles. For most people, the pain from shingles begins as a painful, blistering rash that can last several weeks. However, the effects can last for months or even years. A recombinant zoster vaccine (RZV, Shingrix) has been used since 2017, and is recommended as the preferred shingles vaccine. Shingrix should be administered to adults age 50 years and older as a two-dose series (0.5 ml each), 2 to 6 months apart (0, 2-6 months). Vaccination is more than 90% effective. WHO SHOULD GET THE VACCINE? Are you on the list? You should get vaccinated even if in the past you: º had shingles º received Zostavax º are not sure if you had chickenpox There is no maximum age for getting vaccinated. The CDC recommends that even if you had Zostavax in the past, you should still get Shingrix, as it reduces the risk of shingles and PHN by more than 90% in people 50 and older.

Contact Details

• 300 Columbia Street #112, Kamloops, BC, Canada